
Amarin Corporation PLC
NASDAQ:AMRN

Amarin Corporation PLC?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.002
17.33
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Amarin Corporation PLC hold over its rivals?
What risks and challenges
does Amarin Corporation PLC face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Amarin Corporation PLC.
Provide an overview of the primary business activities
of Amarin Corporation PLC.
What unique competitive advantages
does Amarin Corporation PLC hold over its rivals?
What risks and challenges
does Amarin Corporation PLC face in the near future?
Has there been any significant insider trading activity
in Amarin Corporation PLC recently?
Summarize the latest earnings call
of Amarin Corporation PLC.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Amarin Corporation PLC.
Provide P/S
for Amarin Corporation PLC.
Provide P/E
for Amarin Corporation PLC.
Provide P/OCF
for Amarin Corporation PLC.
Provide P/FCFE
for Amarin Corporation PLC.
Provide P/B
for Amarin Corporation PLC.
Provide EV/S
for Amarin Corporation PLC.
Provide EV/GP
for Amarin Corporation PLC.
Provide EV/EBITDA
for Amarin Corporation PLC.
Provide EV/EBIT
for Amarin Corporation PLC.
Provide EV/OCF
for Amarin Corporation PLC.
Provide EV/FCFF
for Amarin Corporation PLC.
Provide EV/IC
for Amarin Corporation PLC.
Show me price targets
for Amarin Corporation PLC made by professional analysts.
What are the Revenue projections
for Amarin Corporation PLC?
How accurate were the past Revenue estimates
for Amarin Corporation PLC?
What are the Net Income projections
for Amarin Corporation PLC?
How accurate were the past Net Income estimates
for Amarin Corporation PLC?
What are the EPS projections
for Amarin Corporation PLC?
How accurate were the past EPS estimates
for Amarin Corporation PLC?
What are the EBIT projections
for Amarin Corporation PLC?
How accurate were the past EBIT estimates
for Amarin Corporation PLC?
Compare the revenue forecasts
for Amarin Corporation PLC with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Amarin Corporation PLC and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Amarin Corporation PLC against its competitors.
Analyze the profit margins
(gross, operating, and net) of Amarin Corporation PLC compared to its peers.
Compare the P/E ratios
of Amarin Corporation PLC against its peers.
Discuss the investment returns and shareholder value creation
comparing Amarin Corporation PLC with its peers.
Analyze the financial leverage
of Amarin Corporation PLC compared to its main competitors.
Show all profitability ratios
for Amarin Corporation PLC.
Provide ROE
for Amarin Corporation PLC.
Provide ROA
for Amarin Corporation PLC.
Provide ROIC
for Amarin Corporation PLC.
Provide ROCE
for Amarin Corporation PLC.
Provide Gross Margin
for Amarin Corporation PLC.
Provide Operating Margin
for Amarin Corporation PLC.
Provide Net Margin
for Amarin Corporation PLC.
Provide FCF Margin
for Amarin Corporation PLC.
Show all solvency ratios
for Amarin Corporation PLC.
Provide D/E Ratio
for Amarin Corporation PLC.
Provide D/A Ratio
for Amarin Corporation PLC.
Provide Interest Coverage Ratio
for Amarin Corporation PLC.
Provide Altman Z-Score Ratio
for Amarin Corporation PLC.
Provide Quick Ratio
for Amarin Corporation PLC.
Provide Current Ratio
for Amarin Corporation PLC.
Provide Cash Ratio
for Amarin Corporation PLC.
What is the historical Revenue growth
over the last 5 years for Amarin Corporation PLC?
What is the historical Net Income growth
over the last 5 years for Amarin Corporation PLC?
What is the current Free Cash Flow
of Amarin Corporation PLC?
Discuss the annual earnings per share (EPS)
trend over the past five years for Amarin Corporation PLC.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IE |
![]() |
Amarin Corporation PLC
NASDAQ:AMRN
|
303.5m USD | -0.2 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -198 041.5 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
337.7B USD | 15.4 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
325.9B USD | -13 213.5 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
163.2B USD | 14.7 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
142.2B USD | 10.3 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.4B USD | 25.9 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -570.5 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
132.4B AUD | 19.2 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.4B USD | 12 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -65.4 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IE |
![]() |
Amarin Corporation PLC
NASDAQ:AMRN
|
Average EV/EBITDA:
16.3
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -198 041.5 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15.4
|
13%
|
1.2 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
Negative Multiple: -13 213.5 | N/A | N/A |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
14.7
|
17%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10.3
|
6%
|
1.7 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
25.9
|
17%
|
1.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -570.5 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
19.2
|
11%
|
1.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
12
|
11%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -65.4 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.